...
首页> 外文期刊>Journal of gastroenterology and hepatology >The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
【24h】

The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.

机译:血清乙型肝炎e抗原的术前阳性不会影响乙型肝炎病毒相关肝细胞癌的根治性切除后的总体生存。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIM: Previous studies have reported different risk factors for early and late intrahepatic recurrence after resection of hepatocellular carcinoma (HCC). However, the prognostic significance of the risk factors for early and late recurrence has not been clarified. METHODS: A total of 190 Hepatitis B surface antigen-positive patients who received curative resection for HCC were reviewed. We investigated prognostic factors for disease-free and overall survival after resection, and further analyzed the relationship between significant prognostic factors and risk factors for early (14 months) intrahepatic recurrence. RESULTS: The 5-year disease-free and overall survival rates were 43.9% and 71.5%, respectively. In multivariate analysis, adverse prognostic factors for disease-free survival were presence of serum HBeAg, perioperative transfusion, and the presence of portal vein invasion (PVI) and/or intrahepatic metastasis (IM). Multivariate analysis revealed that overall survival was associated with ICG R15, serum albumin, Edmondson-Steiner grade, and the presence of PVI and/or IM. Independent risk factors for early intrahepatic recurrence were perioperative transfusion and PVI and/or IM, whereas positivity for HBeAg was the only risk factor for late recurrence. In addition, post-recurrence survival in patients with late intrahepatic recurrence was completely comparable to that of patients who never experienced recurrence. CONCLUSIONS: The presence of serum HBeAg, the risk factor for late intrahepatic recurrence did not affect overall survival after resection because late recurrence was relatively well controlled by current available treatments. To further improve long-term surgical outcomes, effective treatment and preventive methods for early intrahepatic recurrence should be investigated.
机译:背景与目的:先前的研究报道了切除肝细胞癌(HCC)后早期和晚期肝内复发的不同危险因素。但是,早期和晚期复发的危险因素的预后意义尚未明确。方法:对190例接受肝癌根治性切除术的乙型肝炎表面抗原阳性患者进行了回顾。我们调查了切除后无疾病和总体生存的预后因素,并进一步分析了早期(<或= 14个月)和晚期(> 14个月)肝内复发的重要预后因素与危险因素之间的关系。结果:5年无病生存率和总生存率分别为43.9%和71.5%。在多变量分析中,无病生存的不良预后因素是血清HBeAg的存在,围手术期输血以及门静脉侵犯(PVI)和/或肝内转移(IM)的存在。多变量分析显示,总生存与ICG R15,血清白蛋白,Edmondson-Steiner等级以及PVI和/或IM的存在有关。肝内早期复发的独立危险因素是围手术期输血和PVI和/或IM,而HBeAg阳性则是晚期复发的唯一危险因素。此外,晚期肝内复发患者的复发后生存率与从未经历过复发的患者完全相同。结论:血清HBeAg(肝内晚期复发的危险因素)的存在并不影响切除后的总体生存,因为目前可用的治疗方法对晚期复发的控制相对较好。为了进一步改善长期手术效果,应研究早期肝内复发的有效治疗方法和预防方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号